Suchergebnisse - "Blood advances"

American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism von Ortel, Thomas L., Neumann, Ignacio, Ageno, Walter, Beyth, Rebecca, Clark, Nathan P., Cuker, Adam, Hutten, Barbara A., Jaff, Michael R., Manja, Veena, Schulman, Sam, Thurston, Caitlin, Vedantham, Suresh, Verhamme, Peter, Witt, Daniel M., D. Florez, Ivan, Izcovich, Ariel, Nieuwlaat, Robby, Ross, Stephanie, J. Schünemann, Holger, Wiercioch, Wojtek, Zhang, Yuan, Zhang, Yuqing

“… In August 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the …”
Volltext

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer von Lyman, Gary H., Carrier, Marc, Ay, Cihan, Di Nisio, Marcello, Hicks, Lisa K., Khorana, Alok A., Leavitt, Andrew D., Lee, Agnes Y.Y., Macbeth, Fergus, Morgan, Rebecca L., Noble, Simon, Sexton, Elizabeth A., Stenehjem, David, Wiercioch, Wojtek, Kahale, Lara A., Alonso-Coello, Pablo

“… Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity …”
Volltext

American Society of Hematology 2019 guidelines for immune thrombocytopenia von Neunert, Cindy, Terrell, Deirdra R., Arnold, Donald M., Buchanan, George, Cines, Douglas B., Cooper, Nichola, Cuker, Adam, Despotovic, Jenny M., George, James N., Grace, Rachael F., Kühne, Thomas, Kuter, David J., Lim, Wendy, McCrae, Keith R., Pruitt, Barbara, Shimanek, Hayley, Vesely, Sara K.

“… Background: Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from …”
Volltext

Updated international consensus report on the investigation and management of primary immune thrombocytopenia von Provan, Drew, Arnold, Donald M., Bussel, James B., Chong, Beng H., Cooper, Nichola, Gernsheimer, Terry, Ghanima, Waleed, Godeau, Bertrand, González-López, Tomás José, Grainger, John, Hou, Ming, Kruse, Caroline, McDonald, Vickie, Michel, Marc, Newland, Adrian C., Pavord, Sue, Rodeghiero, Francesco, Scully, Marie, Tomiyama, Yoshiaki, Wong, Raymond S., Zaja, Francesco, Kuter, David J.

“… Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia …”
Volltext

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease von James, Paula D., Connell, Nathan T., Ameer, Barbara, Di Paola, Jorge, Eikenboom, Jeroen, Giraud, Nicolas, Haberichter, Sandra, Jacobs-Pratt, Vicki, Konkle, Barbara, McLintock, Claire, McRae, Simon, R. Montgomery, Robert, O'Donnell, James S., Scappe, Nikole, Sidonio, Robert, Flood, Veronica H., Husainat, Nedaa, Kalot, Mohamad A., Mustafa, Reem A.

“… von Willebrand disease (VWD) is the most common inherited bleeding disorder known in humans. Accurate and timely diagnosis presents numerous challenges. These …”
Volltext

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 von Cuker, Adam, Tseng, Eric K., Nieuwlaat, Robby, Angchaisuksiri, Pantep, Blair, Clifton, Dane, Kathryn, Davila, Jennifer, DeSancho, Maria T., Diuguid, David, Griffin, Daniel O., Kahn, Susan R., Klok, Frederikus A., Lee, Alfred Ian, Neumann, Ignacio, Pai, Ashok, Pai, Menaka, Righini, Marc, Sanfilippo, Kristen M., Siegal, Deborah, Skara, Mike, Touri, Kamshad, A. Akl, Elie, Bou Akl, Imad, Boulos, Mary, Brignardello-Petersen, Romina, Charide, Rana, Chan, Matthew, Dearness, Karin, Darzi, Andrea J., Kolb, Philipp, Colunga-Lozano, Luis E., Mansour, Razan, Morgano, Gian Paolo, Morsi, Rami Z., Noori, Atefeh, Piggott, Thomas, Qiu, Yuan, Roldan, Yetiani, Schünemann, Finn, Stevens, Adrienne, Solo, Karla, Ventresca, Matthew, Wiercioch, Wojtek, Mustafa, Reem A., Schünemann, Holger J.

“… Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE). These evidence-based …”
Volltext

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma von Pasquini, Marcelo C., Hu, Zhen-Huan, Curran, Kevin, Laetsch, Theodore, Locke, Frederick, Rouce, Rayne, Pulsipher, Michael A., Phillips, Christine L., Keating, Amy, Frigault, Matthew J., Salzberg, Dana, Jaglowski, Samantha, Sasine, Joshua P., Rosenthal, Joseph, Ghosh, Monalisa, Landsburg, Daniel, Margossian, Steven, Martin, Paul L., Kamdar, Manali K., Hematti, Peiman, Nikiforow, Sarah, Turtle, Cameron, Perales, Miguel-Angel, Steinert, Patricia, Horowitz, Mary M., Moskop, Amy, Pacaud, Lida, Yi, Lan, Chawla, Raghav, Bleickardt, Eric, Grupp, Stephan

“… Tisagenlecleucel is a CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of pediatric and young adult patients with relapsed/refractory …”
Volltext

American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients von Anderson, David R., Morgano, Gian Paolo, Bennett, Carole, Dentali, Francesco, Francis, Charles W., Garcia, David A., Kahn, Susan R., Rahman, Maryam, Rajasekhar, Anita, Rogers, Frederick B., Smythe, Maureen A., Tikkinen, Kari A.O., Yates, Adolph J., Baldeh, Tejan, Balduzzi, Sara, Brożek, Jan L., Ikobaltzeta, Itziar Etxeandia, Johal, Herman, Neumann, Ignacio, Wiercioch, Wojtek, Yepes-Nuñez, Juan José, Schünemann, Holger J., Dahm, Philipp

“… Background: Venous thromboembolism (VTE) is a common source of perioperative morbidity and mortality. Objective: These evidence-based guidelines from the …”
Volltext

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma von Locke, Frederick L., Rossi, John M., Neelapu, Sattva S., Jacobson, Caron A., Miklos, David B., Ghobadi, Armin, Oluwole, Olalekan O., Reagan, Patrick M., Lekakis, Lazaros J., Lin, Yi, Sherman, Marika, Better, Marc, Go, William Y., Wiezorek, Jeffrey S., Xue, Allen, Bot, Adrian

“… ZUMA-1 demonstrated a high rate of durable response and a manageable safety profile with axicabtagene ciloleucel (axi-cel), an anti-CD19 chimeric antigen …”
Volltext

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma von Vercellino, Laetitia, Di Blasi, Roberta, Kanoun, Salim, Tessoulin, Benoit, Rossi, Cedric, D'Aveni-Piney, Maud, Obéric, Lucie, Bodet-Milin, Caroline, Bories, Pierre, Olivier, Pierre, Lafon, Ingrid, Berriolo-Riedinger, Alina, Galli, Eugenio, Bernard, Sophie, Rubio, Marie-Thérèse, Bossard, Celine, Meignin, Veronique, Merlet, Pascal, Feugier, Pierre, Le Gouill, Steven, Ysebaert, Loic, Casasnovas, Olivier, Meignan, Michel, Chevret, Sylvie, Thieblemont, Catherine

“… Chimeric antigen receptor (CAR) T-cell therapy has emerged as an option for relapsed/refractory aggressive B-cell lymphomas that have failed 2 lines of …”
Volltext

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma von Munshi, Nikhil C., Avet-Loiseau, Herve, Anderson, Kenneth C., Neri, Paola, Paiva, Bruno, Samur, Mehmet, Dimopoulos, Meletios, Kulakova, Margarita, Lam, Annette, Hashim, Mahmoud, He, Jianming, Heeg, Bart, Ukropec, Jon, Vermeulen, Jessica, Cote, Sarah, Bahlis, Nizar

“… The prognostic value of minimal residual disease (MRD) for progression-free survival (PFS) and overall survival (OS) was evaluated in a large cohort of …”
Volltext

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia von Barr, Paul M., Owen, Carolyn, Robak, Tadeusz, Tedeschi, Alessandra, Bairey, Osnat, Burger, Jan A., Hillmen, Peter, Coutre, Steve E., Dearden, Claire, Grosicki, Sebastian, McCarthy, Helen, Li, Jian-Yong, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Hsu, Emily, Szoke, Anita, Kipps, Thomas J., Ghia, Paolo

“… We report long-term follow-up from the RESONATE-2 phase 3 study of the once-daily Bruton's tyrosine kinase inhibitor ibrutinib, which is the only targeted …”
Volltext

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support von Chou, Stella T., Alsawas, Mouaz, Fasano, Ross M., Field, Joshua J., Hendrickson, Jeanne E., Howard, Jo, Kameka, Michelle, Kwiatkowski, Janet L., Pirenne, France, Shi, Patricia A., Stowell, Sean R., Thein, Swee Lay, Westhoff, Connie M., Wong, Trisha E., Akl, Elie A.

“… In July 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the …”
Volltext

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients von Schünemann, Holger J., Cushman, Mary, Burnett, Allison E., Kahn, Susan R., Beyer-Westendorf, Jan, Spencer, Frederick A., Rezende, Suely M., Zakai, Neil A., Bauer, Kenneth A., Dentali, Francesco, Lansing, Jill, Balduzzi, Sara, Darzi, Andrea, Morgano, Gian Paolo, Neumann, Ignacio, Nieuwlaat, Robby, Yepes-Nuñez, Juan J., Zhang, Yuan, Wiercioch, Wojtek

“… In October 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of …”
Volltext

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia von Cuker, Adam, Arepally, Gowthami M., Chong, Beng H., Cines, Douglas B., Greinacher, Andreas, Gruel, Yves, Linkins, Lori A., Rodner, Stephen B., Selleng, Sixten, Warkentin, Theodore E., Wex, Ashleigh, Mustafa, Reem A., Morgan, Rebecca L., Santesso, Nancy

“… Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet …”
Volltext

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing von Middeldorp, Saskia, Nieuwlaat, Robby, Baumann Kreuziger, Lisa, Coppens, Michiel, Houghton, Damon, James, Andra H., Lang, Eddy, Moll, Stephan, Myers, Tarra, Bhatt, Meha, Chai-Adisaksopha, Chatree, Colunga-Lozano, Luis E., Karam, Samer G., Zhang, Yuan, Wiercioch, Wojtek, Schünemann, Holger J., Iorio, Alfonso

“… Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial …”
Volltext

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease von Connell, Nathan T., Flood, Veronica H., Brignardello-Petersen, Romina, Abdul-Kadir, Rezan, Arapshian, Alice, Couper, Susie, Grow, Jean M., Kouides, Peter, Laffan, Michael, Lavin, Michelle, Leebeek, Frank W.G., O'Brien, Sarah H., Ozelo, Margareth C., Tosetto, Alberto, Weyand, Angela C., James, Paula D., Kalot, Mohamad A., Husainat, Nedaa, Mustafa, Reem A.

“… von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients. These …”
Volltext

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain von Brandow, Amanda M., Carroll, C. Patrick, Creary, Susan, Edwards-Elliott, Ronisha, Glassberg, Jeffrey, Hurley, Robert W., Kutlar, Abdullah, Seisa, Mohamed, Stinson, Jennifer, Strouse, John J., Yusuf, Fouza, Zempsky, William, Lang, Eddy

“… Background: The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity …”
Volltext

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults von DeBaun, M.R., Jordan, L.C., King, A.A., Schatz, J., Vichinsky, E., Fox, C.K., McKinstry, R.C., Telfer, P., Kraut, M.A., Daraz, L., Kirkham, F.J., Murad, M.H.

“… Central nervous system (CNS) complications are among the most common, devastating sequelae of sickle cell disease (SCD) occurring throughout the lifespan …”
Volltext

American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy von Witt, Daniel M., Nieuwlaat, Robby, Clark, Nathan P., Ansell, Jack, Holbrook, Anne, Skov, Jane, Shehab, Nadine, Mock, Juliet, Myers, Tarra, Dentali, Francesco, Crowther, Mark A., Agarwal, Arnav, Bhatt, Meha, Khatib, Rasha, Riva, John J., Zhang, Yuan, Guyatt, Gordon

“… In July 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the …”
Volltext